uniQure NV (QURE)
5.02
-0.05
(-0.99%)
USD |
NASDAQ |
May 17, 16:00
5.02
0.00 (0.00%)
After-Hours: 20:00
uniQure Free Cash Flow: -135.36M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -135.36M |
| December 31, 2023 | -153.08M |
| September 30, 2023 | -161.25M |
| June 30, 2023 | -251.44M |
| March 31, 2023 | -213.62M |
| December 31, 2022 | -162.75M |
| September 30, 2022 | -153.64M |
| June 30, 2022 | -148.52M |
| March 31, 2022 | 285.90M |
| December 31, 2021 | 270.52M |
| September 30, 2021 | 281.29M |
| June 30, 2021 | 292.25M |
| March 31, 2021 | -153.62M |
| December 31, 2020 | -144.31M |
| September 30, 2020 | -132.41M |
| June 30, 2020 | -119.80M |
| March 31, 2020 | -113.51M |
| December 31, 2019 | -105.33M |
| September 30, 2019 | -96.11M |
| June 30, 2019 | -92.75M |
| March 31, 2019 | -85.86M |
| Date | Value |
|---|---|
| December 31, 2018 | -80.28M |
| September 30, 2018 | -80.80M |
| June 30, 2018 | -76.26M |
| March 31, 2018 | -78.30M |
| December 31, 2017 | -69.85M |
| September 30, 2017 | -70.51M |
| June 30, 2017 | -81.55M |
| March 31, 2017 | -85.40M |
| December 31, 2016 | -89.36M |
| September 30, 2016 | -95.09M |
| June 30, 2016 | -69.59M |
| March 31, 2016 | -2.897M |
| December 31, 2015 | -0.554M |
| September 30, 2015 | 6.878M |
| June 30, 2015 | -3.804M |
| March 31, 2015 | -63.26M |
| December 31, 2014 | -59.34M |
| September 30, 2014 | -51.73M |
| June 30, 2014 | -29.02M |
| March 31, 2014 | -20.22M |
| December 31, 2013 | -13.98M |
Free Cash Flow Range, Past 5 Years
-251.44M
Minimum
Jun 2023
292.25M
Maximum
Jun 2021
-60.38M
Average
-133.88M
Median
Free Cash Flow Benchmarks
| ProQR Therapeutics NV | -43.28M |
| Merus NV | -150.28M |
| argenx SE | -- |
| Pharming Group | -3.493M |
| Pharvaris NV | -100.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -60.58M |
| Cash from Investing (Quarterly) | 63.98M |
| Free Cash Flow Per Share (Quarterly) | -1.300 |
| Free Cash Flow to Equity (Quarterly) | -63.29M |
| Free Cash Flow to Firm (Quarterly) | -53.23M |
| Free Cash Flow Yield | -56.40% |